EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 22 filers reported holding EVOKE PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,000 | -36.8% | 44,000 | +49.7% | 0.00% | – |
| Q3 2021 | $38,000 | -88.5% | 29,400 | -87.8% | 0.00% | – |
| Q2 2021 | $330,000 | -65.1% | 241,000 | -53.3% | 0.00% | – |
| Q1 2021 | $945,000 | +37.0% | 516,400 | +93.0% | 0.00% | – |
| Q4 2020 | $690,000 | +32.4% | 267,514 | +141.1% | 0.00% | – |
| Q3 2020 | $521,000 | +1984.0% | 110,968 | +275.1% | 0.00% | – |
| Q3 2019 | $25,000 | -62.1% | 29,585 | -71.6% | 0.00% | – |
| Q2 2019 | $66,000 | +106.2% | 104,199 | +710.9% | 0.00% | – |
| Q2 2018 | $32,000 | -44.8% | 12,850 | -50.0% | 0.00% | – |
| Q4 2017 | $58,000 | +190.0% | 25,723 | +154.4% | 0.00% | – |
| Q4 2016 | $20,000 | – | 10,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
| Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
| Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
| STATE STREET CORP | 72,800 | $41,000 | 0.00% |
| MORGAN STANLEY | 9,606 | $5,000 | 0.00% |